Worth subscribing, Union Shadow Medical (688271), stock bar on July 29 released its offering prospectus, which Union Shadow Medical subscription time for August 10, 2022, Union Shadow Medical's offering price is 109.88 yuan / share, the number of shares issued online is 10 million. The company is committed to providing global customers with high-performance medical imaging equipment, radiation therapy products, life science instruments and medical digitalization, intelligent solutions. The company is headquartered in Shanghai, while in the United States, Malaysia, the United Arab Emirates, Poland and other places to set up regional headquarters and research and development centers, in Shanghai, Changzhou, Wuhan, the United States, Houston, production capacity layout, has established globalization of research and development, production and service network. The United States medical worth subscribing to the last 1 month from the listing of new stocks, the possibility of getting a gain is relatively low, broken stocks in mid-July after the increase in the number of shares, so the subscription needs to be cautious. However, last week's listing has improved, you can also pay attention to this week's listing of stocks to make subsequent judgments. Since its establishment, the company has continued to invest in high-intensity research and development, and is committed to conquering the core technology in the field of medical imaging equipment, radiation therapy products and other large-scale medical equipment; after many years of efforts, the company has built a complete product line layout including medical imaging equipment, radiation therapy products, life science instruments. As of the end of the reporting period, the Company has launched more than 80 products to the market, including magnetic **** vibration imaging systems (MR), X-ray computed tomography systems (CT), X-ray imaging systems (XR), molecular imaging systems (PET/CT, PET/MR), medical linear gas pedal systems (RT), and life science instruments. In the field of digital diagnosis and treatment, the Company provides UnionPhoto Medical Cloud Service based on the UnionPhoto Cloud System Architecture, realizing the cloud collaboration of equipment and applications as well as the enjoyment of medical resources***, and providing comprehensive solutions for end customers. Since its launch, the Company's products have been installed in nearly 900 tertiary hospitals nationwide, and have been widely recognized by end customers. According to the "2020 China Hospital Ranking - National Comprehensive Ranking" released by the Institute of Hospital Management of Fudan University, the top 10 medical institutions in China are all users of the Company, and among the top 50 medical institutions, 49 are users of the Company. According to the caliber of new domestic units in 2020, the company's MR, CT, PET/CT, PET/MR and DR products are ranked at the forefront of the industry, of which the MR products ranked first in the domestic new market share, and the 1.5T and 3.0T MR ranked first and fourth, respectively; the CT products ranked first in the domestic new market share, and the CT with less than 64 rows ranked first, and the CT with 64 rows and above ranked fourth; the PET/CT products ranked first, and the CT with 64 rows and above ranked fourth. CT products ranked first in terms of new market share in China, with CT below 64 rows ranked first and CT above 64 rows and above ranked fourth; PET/CT and PET/MR products ranked first in terms of new market share in China; and DR and mobile DR products ranked second and first in terms of new market share in China respectively. Market Position The Company's products have a leading market share in the domestic newly-added equipment market. According to the data of Scorchlight Consulting, according to the caliber of the newly-added unit share in 2020, the Company's MR, CT, PET/CT, PET/MR and DR products ranked at the forefront of the industry. Among them, MR products ranked first in the domestic new market share, and 1.5T and 3.0T MR ranked first and fourth respectively; CT products ranked first in the domestic new market share, and CT below 64 rows ranked first, and CT of 64 rows and above ranked fourth; PET/CT and PET/MR products ranked first in the domestic new market share; DR and mobile DR products ranked second in the domestic new market share respectively; and DR and mobile DR products ranked second in the domestic new market share. DR and mobile DR products ranked second and first in terms of new market share in China respectively. Our main competitors include GE Healthcare, Siemens Healthcare, Philips Healthcare, MediTech, Wandong Medical (600055) and Neusoft Medical, etc. (1) GE Healthcare is the world's largest medical company. (1) GE Healthcare is the world's leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. Through the provision of intelligent devices, data analysis, software applications and services, GE Healthcare realizes a full range of precision healthcare from disease diagnosis, treatment to monitoring. Its products cover a full range of high-end medical imaging equipment, including interventional X-ray imaging systems (DSA), mammography systems, CT systems, MR systems, ultrasound systems and molecular imaging systems. (2) Siemens Healthcare is one of the leaders in diagnostic imaging. Siemens Medical's medical imaging product portfolio includes CT systems, MR systems, MI systems, X-ray systems, diagnostic ultrasound systems and medical image processing software. Siemens Healthcare acquired Varian in 2021 to expand its product line into radiotherapy equipment. (3) Philips Healthcare specializes in cardiology, oncology, critical care and women's health, providing solutions in the areas of disease prevention, diagnostic and therapeutic radiology, health management and monitoring. Philips medical imaging systems mainly include X-ray systems, CT systems, MR systems, ultrasound systems and molecular imaging systems. (4) Headquartered in Stockholm, Sweden, MediTech provides radiotherapy-related equipment and clinical management services for cancer and brain diseases, with operations in more than 120 countries and regions, and its advanced technologies and innovative solutions applied in more than 6,000 healthcare institutions worldwide. (5) Vantone Medical specializes in the research and development, manufacturing and production of imaging medical devices and diagnostic imaging services. Its product lines cover large imaging products, mobile imaging products, diagnostic imaging services (Miles Cloud) and diagnostic ultrasound products (Vantone Yum). (6) Neusoft Medical is mainly engaged in the research and development, production, sales and related solutions and services of large-scale medical diagnostic and therapeutic equipments, with its product lines covering computed tomography imaging systems, magnetic **** vibration imaging systems, digital subtraction angiography systems, general X-ray imaging equipments, ultrasonic diagnostic equipments, nuclear medicine imaging equipments, radiation therapy products, in vitro diagnostic equipments and reagents. (7) Myriad Medical is mainly engaged in the research and development, manufacturing, marketing and service of medical devices, and its main products cover three major areas: life information and support, in vitro diagnostics, and medical imaging, of which the medical imaging products include diagnostic ultrasound systems, digital X-ray imaging systems, and PACS. After reading the company profile of Lianyin Medical and the main product development and the information on Lianyin Medical's subscription, the following is to expand on the information on What is IPO, and when is the best time to apply. IPO is to obtain the stock primary market, the secondary market between the very low risk spread income, not to participate in the secondary market speculation, not only the principal is very safe, the income is also relatively stable, is a prudent investor ideal investment choice. IPO is one of the lowest risk and stable return investment methods in the stock market. IPO refers to the Initial Public Offering (translated into Initial Public Offerings, or IPO for short), which is the process by which a company issues shares for the first time publicly to investors through the stock exchange, with a view to raising funds for corporate development. The best time to apply for new shares Investors through the securities company trading system order subscription is to pay attention to the time period, the reason is that a new stock can only order once, need to avoid the order subscription peak period, so that not only the subscription of the probability of winning, and a high success rate. After research, investors commissioned the most intensive time period and the most signed time period is in the morning 10:30-11:30 and 1:00-2:00 pm, the probability of winning is relatively large.